NCT04065399 2026-03-18
AUGMENT-101
Syndax Pharmaceuticals
Phase 1/2 Recruiting
Clinical Trials
4 trialsNCT06610682 2025-12-10
Feasibility of CSF and Plasma ctDNA in BRAF-altered Glioma During Treatment With Plixorafenib
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Recruiting
NCT05748093 2024-08-09
OSIBOOST 2
Maastricht University Medical Center
Phase 4 Recruiting
NCT06014489 2024-01-18
HO171
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2 Recruiting